A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans

Although a cure for HCV is on the near horizon, emerging drug cocktails will be expensive, associated with side-effects and resistance making a global vaccine an urgent priority given the estimated high incidence of infection around the world. Due to the highly heterogeneous nature of HCV, an effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Law, John Lok Man, Chen, Chao, Wong, Jason, Hockman, Darren, Santer, Deanna M., Frey, Sharon E., Belshe, Robert B., Wakita, Takaji, Bukh, Jens, Jones, Christopher T., Rice, Charles M., Abrignani, Sergio, Tyrrell, D. Lorne, Houghton, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602185/
https://www.ncbi.nlm.nih.gov/pubmed/23527266
http://dx.doi.org/10.1371/journal.pone.0059776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602185/
https://www.ncbi.nlm.nih.gov/pubmed/23527266
http://dx.doi.org/10.1371/journal.pone.0059776

Ejemplares similares